Search for: "Editors" Results 7721 - 7740 of 61,813
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Oct 2022, 6:23 am by Amanda L. White Eagle
Editors’ note: This is part of an ongoing series on issues of Native sovereignty before the U.S. [read post]
Lin Grensing-Pophal is a Contributing Editor at HR Daily Advisor. [read post]
Editor’s Note: In this blog series, we are getting to know the members of the Texas Young Lawyers Association Board of Directors. [read post]
9 Oct 2022, 9:03 am
I wonder if the NYT editors considered not taunting us with the phrase "before the procedure was legalized. [read post]
9 Oct 2022, 7:01 am by Farah Pandith, Jacob Ware
Editor’s Note: In recent years, men have had the dubious distinction of dominating the ranks of terrorists, but that may be changing. [read post]
9 Oct 2022, 6:36 am by jonathanturley
TAI Vice President and Executive Editor is Jessica McCreight who reportedly is a former Obama communications staff member. [read post]
9 Oct 2022, 6:30 am
Majarian, Skadden, Arps, Slate, Meagher & Flom LLP, on Sunday, October 9, 2022 Editor's Note: Stephen F. [read post]
9 Oct 2022, 5:00 am by Paul Caron
Boston Globe, Jack Thomas, Journalist Who Poignantly Wrote of His Terminal Diagnosis, Dies at 83: A reporter, columnist, city editor, and ombudsman during more than four decades at the Globe, Mr. [read post]
8 Oct 2022, 6:31 am
Schuette, Mayer Brown LLP, on Saturday, October 8, 2022 Editor's Note: Laura D. [read post]
8 Oct 2022, 3:58 am by Rob Robinson
Editor’s Note: The results of the recent Fall 2022 eDiscovery Business Confidence Survey present the impact of key issues on the business of eDiscovery. [read post]
7 Oct 2022, 9:06 pm by Guest Contributor
Editor’s note: This is a letter sent by a large coalition of consumer and industry groups to Jane Henney, the chair of the Independent Expert Panel – FDA Human Foods Program of the Reagan-Udall Foundation, that is charged with investigating operations at the Food and Drug Administration. [read post]
7 Oct 2022, 1:32 pm by Tom Lamb
On September 23, 2022, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 8-4 against the Copiktra benefit-risk profile, as reported in this Endpoint News piece by Senior Editor Zachary Brennan, "FDA adcomm takes down Secura Bio's leukemia drug after final trial results show potential OS detriment". [read post]
7 Oct 2022, 8:28 am by Eric S. Solotoff
Eric Solotoff is the editor of the New Jersey Family Legal Blog and the Co-Chair of the Family Department of Fox Rothschild LLP. [read post]
7 Oct 2022, 8:21 am by INFORRM
On 1 November 2021, three days after the publication of the President’s Report on Transparency, Mostyn J handed down judgment in a case called BT v CU [2021] EWFC 87; [2022] 1 WLR 1349. [read post]
7 Oct 2022, 6:31 am
Ho and Hong Tran, Orrick, Herrington & Sutcliffe LLP, on Friday, October 7, 2022 Editor's Note: Michael Delikat and J. [read post]
7 Oct 2022, 6:30 am
Posted by the Harvard Law School Forum on Corporate Governance, on Friday, October 7, 2022 Editor's Note: This roundup contains a collection of the posts published on the Forum during the week of September 30-October 6, 2022. [read post]
7 Oct 2022, 4:16 am by Rob Robinson
Editor’s Note: One of the most accurate and detailed sources for ongoing updates on the Ukraine crisis is the Ukraine Conflict Update from the Institute for the Study of War. [read post]